MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/por.s360044

Медицинская библиотека · Pragmatic and observational research · 2022

Characterisation of the Australian Adult Population Living with Asthma: Severe - Exacerbation Frequency, Long-Term OCS Use and Adverse Effects.

Hancock Kerry L, Bosnic-Anticevich Sinthia, Blakey John D, Hew Mark, Chung Li Ping, Cvetkovski Biljana, Claxton Scott, Del Fante Peter, Denton Eve, Doan Joe, Ranasinghe Kanchanamala, Morgan Lucy, Sharma Anita, Smith Peter K, Stewart Deb, Thompson Philip J, Wiseman Russell, Upham John W, Yan Kwok Y, Carter Victoria, Dhillon Kiranjeet, Heraud Florian, Le Thao, Vella Rebecca, Price David, OPCA Improving Asthma outcomes in Australia Research Group

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Asthma poses a significant burden for the Australian population. Understanding severe exacerbation rates, and steroid-related burden for adults diagnosed with asthma stands to offer insights into how this could be reduced.

METHODS

Electronic medical records (EMR) and questionnaires from the Optimum Patient Care Research Database Australia (OPCRDA) were utilised retrospectively. OPCRDA is a real-world database with >800,000 medical records from Australian primary care practices. Outcomes were severe asthma exacerbations in Australian adults, over a 12-month period, stratified by Global Initiative for Asthma (GINA) treatment intensity steps, and steroid associated comorbidities.

RESULTS

Of the 7868 adults treated for asthma, 19% experienced at least one severe exacerbation in the last 12-months. Severe exacerbation frequency increased with treatment intensity (≥1 severe exacerbation GINA 1 13%; GINA 4 23%; GINA 5a 33% and GINA 5b 28%). Questionnaire participants reported higher rates of severe exacerbations than suggested from their EMR (32% vs 23%) especially in steps 1, 4 and 5. Patients repeatedly exposed to steroids had an increased risk of osteoporosis (OR 1.95, 95% CI 1.43-2.66) and sleep apnoea (OR 1.78, 95% CI 1.30-2.46).

CONCLUSION

The Australian population living with GINA 1, 4, 5a and 5b asthma have high severe exacerbation rates and steroid-related burden, especially when compared to other first world countries, with these patients needing alternative strategies or possibly specialist assessment to better manage their condition.

Для цитирования: Hancock Kerry L, Bosnic-Anticevich Sinthia, Blakey John D, Hew Mark, Chung Li Ping, Cvetkovski Biljana, Claxton Scott, Del Fante Peter, Denton Eve, Doan Joe, Ranasinghe Kanchanamala, Morgan Lucy, Sharma Anita, Smith Peter K, Stewart Deb, Thompson Philip J, Wiseman Russell, Upham John W, Yan Kwok Y, Carter Victoria, Dhillon Kiranjeet, Heraud Florian, Le Thao, Vella Rebecca, Price David, OPCA Improving Asthma outcomes in Australia Research Group. Characterisation of the Australian Adult Population Living with Asthma: Severe - Exacerbation Frequency, Long-Term OCS Use and Adverse Effects.. Pragmatic and observational research. 2022. DOI: 10.2147/por.s360044.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.